ArticleJournal of the advanced practitioner in oncology

Inotuzumab Ozogamicin in Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia.

Sherry Williams et al.PubMed ↗Full text ↗

No numbers read from the abstract.